Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
โ Scribed by Iacopo Petrini; Monica Lencioni; Miriam Ricasoli; Mauro Iannopollo; Cinzia Orlandini; Filippo Oliveri; Carlo Bartolozzi; Sergio Ricci
- Book ID
- 105993785
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 261 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND There is no effective systemic therapy for patients with hepatocellular carcinoma. A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerabili
## BACKGROUND. Inoperable hepatocellular carcinoma is an incurable malignancy with no accepted standard therapy. Chemotherapy has demonstrated occasional responses and the need is great for a new and effective agent. Therefore the authors conducted this Phase II trial of a novel thymidylate syntha